Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1301840 | 1.00 | CYP3A4 (0.38) | CYP3A4SMN1; SMN2LMNAUSP2MAPT | |
| SCHEMBL8015606 | 0.88 | CYP3A4 (0.36) | CYP3A4SMN1; SMN2LMNAUSP2MAPT | |
| SCHEMBL221749 | 0.83 | ALDH1A1 (0.50) | CYP3A4SMN1; SMN2LMNAUSP2MAPT | |
| SCHEMBL74779 | 0.83 | ALDH1A1 (0.50) | CYP3A4SMN1; SMN2LMNAUSP2MAPT | |
| SCHEMBL271027 | 0.83 | ALDH1A1 (0.50) | CYP3A4SMN1; SMN2LMNAUSP2MAPT | |
| SCHEMBL16124303 | 0.80 | ALDH1A1 (0.39) | SMN1; SMN2LMNAALDH1A1ALOX15HSD17B10 | |
| SCHEMBL22022746 | 0.80 | CYP3A4 (0.35) | CYP3A4SMN1; SMN2ALDH1A1HSD17B10TSHR | |
| SCHEMBL31217853 | 0.79 | TSHR (0.47) | CYP3A4SMN1; SMN2LMNAUSP2MAPT | |
| SCHEMBL64376 | 0.79 | — | — | |
| SCHEMBL15237136 | 0.78 | ALDH1A1 (0.41) | CYP3A4SMN1; SMN2LMNAUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-3586961-B1 | METHOD FOR MANUFACTURING CATALYST LIQUID | KURARAY CO (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-11628430-B2 | Method for manufacturing catalyst liquid | KURARAY CO., LTD. (JP) | 2023-04-18 | — | — | US | disclosed |
| CN-110290872-B | Method for producing catalyst liquid | 株式会社可乐丽 | 2022-10-18 | — | — | CN | disclosed |
| US-8367618-B2 | Cyclosporin analogues for preventing or treating hepatitis C infection | ENANTA PHARMACEUTICALS, INC. (US) | 2013-02-05 | — | — | US | disclosed |
| US-20110266361-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20100196316-A1 | CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION | ENANTA PHARMACEUTICALS, INC. | 2010-08-05 | — | — | US | disclosed |
| US-7041619-B2 | Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines | KURARAY CO., LTD. (JP) | 2006-05-09 | — | — | US | disclosed |
| EP-1249455-B1 | Phosphorus-containing molecules and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines | KURARAY CO (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-20040260118-A1 | Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines | KURARAY CO. LTD. (JP) | 2004-12-23 | — | — | US | disclosed |
| US-6790985-B2 | USEFUL AS COMPONENTS OF CATALYSTS ACCELERATING TELOMERIZATION OF A CONJUGATED DIENE AND AN ACTIVE HYDROGEN COMPOUND | KURARAY CO., LTD. (JP) | 2004-09-14 | — | — | US | disclosed |
| US-20020183196-A1 | Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines | KURARAY CO. LTD, (JP) | 2002-12-05 | — | — | US | disclosed |
| EP-1249455-A1 | Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines | Kuraray Co., Ltd. (JP) | 2002-10-16 | — | — | EP | disclosed |
| EP-0704417-B1 | Process for producing octadienes | KURARAY CO (JP) | 1999-01-20 | — | — | EP | disclosed |
| US-5763718-A | Process for producing octadienes | KURARAY CO., LTD. (JP) | 1998-06-09 | — | — | US | disclosed |
| EP-0704417-A2 | Process for producing octadienes | KURARAY CO., LTD. (JP) | 1996-04-03 | — | — | EP | disclosed |
| EP-0296550-B1 | Phosphonium salts and processes for production of and uses for the same | KURARAY CO (JP) | 1993-12-29 | — | — | EP | disclosed |
| US-5100854-A | Telomerization catalysts | KURARAY CO., LTD. (JP) | 1992-03-31 | — | — | US | disclosed |
| US-4992609-A | Telomerization catalysts | KURARAY CO., LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| US-4927960-A | TELOMERIZATION CATALYST | KURARAY COMPANY, LTD. (JP) | 1990-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11628430-B2 | Method for manufacturing catalyst liquid | OSGEP, PNP, ALK | CYP3A4 297/4885SMN1; SMN2 1434/4885LMNA 1081/4885 |
| US-20100196316-A1 | CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION | HAVCR2, CHP1, PTPRC | CYP3A4 434/4885SMN1; SMN2 4279/4885LMNA 3948/4885 |
| US-20040260118-A1 | Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines | PHOSPHO1, INPP5B, PIP5K1A | CYP3A4 2126/4885SMN1; SMN2 3584/4885LMNA 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.